



DEVELOPMENT AND VALIDATION OF A STABILITY INDICATING HPTLC METHOD FOR 
DETERMINATION OF EPERISONE HYDROCHLORIDE IN BULK DRUG 
Original Article 
 
VISHAL R. PAGAR*, SUGANDHA V. MULGUND 
Department of Quality Assurance Techniques, STES’s Sinhgad College of Pharmacy, Vadgaon(Bk), Pune 411041, India 
Email: vishalpagar00@gmail.com 
Received: 24 Jul 2014 Revised and Accepted: 05 Sep 2014 
ABSTRACT 
Objective: A new, economical, precise and accurate stability indicating HPTLC method was developed and validated for the determination of 
Eperisone hydrochloride in bulk drug.  
Methods: Sample and standard solutions of Eperisone hydrochloride was applied on precoated silica gel G 60 F254
Results: The calibration curve was found to be linear between 100 to 700 ng/spot for Eperisone hydrochloride with correlation coefficients 0.999. 
The R
 HPTLC plate and the plate was 
developed using Toluene: Chloroform: Ethanol (4:4:1v/v/v) as mobile phase. The detection was performed at 266 nm 
f value for Eperisone hydrochloride was found to be 0.26±0.03. The LOD and LOQ were found to be 100 ng/spot and 300 ng/spot for 
Eperisone hydrochloride. The selected drug was subjected to acid, alkali and oxidative degradation and study revealed, Eperisone hydrochloride is 
well resolved from pure form with significant differences in their Rf 
Conclusion: The proposed method has been validated as per ICH Q2 (R1) guidelines. This method can be used for routine quality control analysis of 
Eperisone hydrochloride in bulk drug. 
this method can be successfully employed for quantitative analysis of Eperisone 
hydrochloride in bulk drug.  
Keywords: Validation, Eperisone hydrochloride, HPTLC, Chromatography. 
 
INTRODUCTION  
Eperisone hydrochloride is used as an antispasmodic and centrally 
acting muscle relaxant in treatment of acute and chronic muscle 
spasm [1]. Chemically it is 4'-ethyl-2-methyl-3-
piperidinopropiophenone hydro chloride. It exists as a white 
crystalline powder, odorless, slightly soluble in water and freely 
soluble in alcohol, chloroform and methanol [1]. Literature survey 
revealed few spectrophotometric [2,3], RP-HPLC [[4,5,6],7]
 
, HPTLC 
[8] and LC-ESI-MS in human plasma [9,10] methods for the 
determination of Eperisone hydrochloride either as single or in 
combination with other drug. But, to the best of our knowledge, a 
simple, specific and economical method for estimation of Eperisone 
hydrochloride by HPTLC for routine laboratory analysis is not yet 
reported. So the aim of present work was to develop and validate 
stability indicating HPTLC method for determination and 
quantitative estimation of Eperisone hydrochloride. 
Fig. 1: Chemical structure of Eperisone hydrochloride 
 
MATERIALS AND METHODS 
Instrumentation  
Pre-coated silica gel 60F254
Chemicals and reagents 
 aluminium plates (10 x 10 cm, 250 μm 
thickness; Merck, Germany), Automatic TLC sampler 4 (Camag, 
Switzerland), twin trough chamber (10 x 10 cm; Camag, Switzerland), 
UV chamber (Camag, Switzerland), TLC scanner 4 (Camag, 
Switzerland), winCATS version 1.4.6 software (Camag, Switzerland) 
were used in the study. Ultrasonic bath (PowerSonic405, Hwashin 
technology, Korea) and Electronic Balance Shimadzu AX200, 
(Shimadzu Corporation, Japan) were used in the study.  
Methanol, Toluene, Chloroform are used were of analytical grade. 
 Eperisone hydrochloride was obtained as gift sample from Sharon 
Biomedicine, India Ltd Mumbai. Tablet Eprisan®
Experimental 
 (Eisai 
Pharmaceuticals India Pvt. Ltd) was purchased from local market, 
containing Eperisone hydrochloride 50 mg per tablet. 
Preparation of standard solutions 
Standard stock solution of Eperisone hydrochloride was prepared by 
dissolving 10 mg of accurately weighed Eperisone hydrochloride in 
10 ml of methanol. This standard solution was further diluted with 
the same solvent to obtain 10 μg/ml of Eperisone hydrochloride.  
Selection of mobile phase 
A trial and error method was used to optimize the mobile phase on 
which different mobile phases were tried. The solvent system of 
Toluene: Chloroform: Ethanol in the ratio 4:4:1v/v/v was the most 
appropriate mobile phase for the HPTLC analysis of Eperisone 
hydrochloride.  
Application of standard solutions  
HPTLC pre-coated plate of silica gel G 60 F250
Calibration curve for Eperisone hydrochloride 
 (10×10) was employed 
for the spotting of standard solutions. 10 µg/ml standard solution of 
100, 200, 300, 400, 500, 600 and 700 ng/band of Eperisone 
hydrochloride were applied in the seven tracks respectively. 
Adequate dilutions were made from standard stock solution to 
obtained concentration of 100, 200, 300, 400, 500, 600 and 700 
ng/band respectively. The relationship between peak area and 
concentration was established by the simple regression equation 
method. The regression equation was obtained and this relationship 
is presented in the calibration curve (Figure 4).  
Development of spot 
Twin Trough chamber containing 10 ml of mobile phase system was 
used for developing the spotted plate and saturated for 15 minutes.  
The plate were dried after development and viewed under UV lamp 
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to evaluate the spot obtained. The spot were uniform and there was 
no tailing.  
Scanning by HPTLC scanner  
After setting up the instrument parameters, the spot was scanned 
from 200 – 400 nm and the spot showed maximum absorption at 
266 nm using the Camag TLC scanner 4. The Rf
Assay of tablet formulation 
 values were found to 
be 0.26 for Eperisone hydrochloride. Typical chromatogram 
obtained for Eperisone hydrochloride is shown in (Figure 2). 
Ten tablets of Eprisan® containing 50 mg of Eperisone 
hydrochloride were weighed, average weight was determine and 
triturate to fine powder. Tablet powder equivalent to 10 mg of 
Eperisone hydrochloride was transferred in 100 ml volumetric flask 
and dissolved in methanol. The solution was sonicated for 20 min 
and filtered through Whatmman filter paper No.41. The filtrate was 
appropriately diluted with methanol to obtained 50 μg/ml of 
Eperisone hydrochloride. The plate was developed under previously 
described chromatographic conditions. The peak area was measured 
at 266 nm and concentration in the sample were determine using 
multilevel calibration developed on the same plate under the same 
condition using the linear regression equation (Table 1). 
Method validation 
The method was validated for linearity, accuracy and intra-day and 
inter-day precision and specificity, in accordance with ICH 
guidelines Q2 (R1
Linearity and range 
).  
Response to Eperisone hydrochloride was linear in the 
concentration range of 100 - 700 ng/spot. The regression equations 
were y = 12.69 x + 131 respectively, where y is response and x the 
concentration of drug. The correlation coefficient were 0.999  
Method precision 
Repeatability  
The precision of the method was checked by repeated analysis of (n 
= 6) standard solutions of Eperisone Hydrochloride (400 ng/band). 
Percentage relative standard deviation (% RSD) value was found to 
be below 2% which indicated that proposed method is precise 
(Table 2). 
Intermediate precision  
The intra-day and inter-day precision of the proposed method was 
determined by analyzing the corresponding responses 6 times on 
the same day and on 3 different days over a period of 1 week for 
standard solutions of 400 ng/band Eperisone Hydrochloride. The 
results were reported in terms of relative standard deviation (RSD) 
(Table 2). 
Accuracy (% Recovery)  
The accuracy of the method was determined by calculating 
recoveries of Eperisone hydrochloride by the standard addition 
method. Known amount of standard of Eperisone hydrochloride 
(80%, 100%, and 120%) was added to sample solutions prepared 
from tablet dosage form. The amounts of Eperisone hydrochloride 
was estimated by substituting values in the regression equations (y 
= 12.69 x + 131). The values prove that the method is accurate 
(Table 3).  
Limit of Detection (LOD) and Limit of Quantitation (LOQ) 
The limit of detection (LOD) is defined as the lowest concentration of 
an analyte that an analytical process can reliably differentiate from 
back-ground levels. In this study, LOD and LOQ were based on the 
standard deviation of the response and the slope of the 
corresponding curve using the following equations- 
LOD = 3.3 σ/S and LOQ = 10 σ/S 
Where, σ is the standard deviation of the signal to noise ratio of the 
sample and S is the slope of the related calibrations graphs. 
The limit of quantification (LOQ) is defined as the lowest 
concentration of the standard curve that can be measured with an 
acceptable accuracy, precision and variability. Sven sets of known 
concentrations (100-700 ng/band) were prepared and scanned. By 
using these spectra, regression equation was obtained. By taking 
average of slopes and standard deviation of y-intercept, LOD and 
LOQ were calculated. The values of LOD and LOQ are given. 
Specificity 
Specificity study was performed by analyzing standard solution of 
drug and sample. The spot for Eperisone hydrochloride in sample 
was confirmed by comparing its Rf
Forced degradation studies 
 of sample spot with the spot 
obtained from standard solution  
Acid degradation 
20 mg of pure drug was transferred to the round bottom flask. To 
this, 40 ml of 0.1M HCL was added and this reaction mixture was 
refluxed at 800
Alkali degradation 
C for about 3 hrs. After every 30 min, 5 ml of refluxed 
sample was removed. Further, 1 ml of the above solution was 
neutralized using 1 ml of 0.1M NaOH solution and then diluted to 10 
ml with diluents to obtain concentration of 50 µg/ml of Eperisone 
hydrochloride.  
20 mg of pure drug was transferred to the round bottom flask. To 
this, 40 ml of 0.1M NaOH was added and this reaction mixture was 
refluxed at 800
Hydrogen peroxide degradation 
c for about 3 hrs. After every 30 min, 5 ml of refluxed 
sample was removed. Further, 1 ml of the above solution was 
neutralized using 1 ml of 0.1M HCL solution and then diluted to 10 
ml with diluents to obtain concentration of 50 µg/ml of Eperisone 
hydrochloride.  
20 mg of pure drug was transferred to round bottom flask. To this 
40 ml of 3% H2O2
RESULTS AND DISCUSSION 
 was added and this reaction mixture was kept at 
room temperature for about 4 hrs. After every 1 hr, 5 ml of sample 
was removed. Further 1 ml of the above solution was diluted to 10 
ml with diluent to obtain concentration of 50µg/ml.  
Linearity were found to be linear in the concentration range of 100-
700 ng/spot for Eperisone hydrochloride withr2= 0.999 respectively 
in mobile phase Toluene: Chloroform: Ethanol in the ratio 
4:4:1v/v/v. The detection was done at 266 nm Rf 
 
value was found to 
be 0.26 for Eperisone hydrochloride. The proposed method was also 
evaluated by the assay of commercially available tablet and % assay 
was found to be 101% for Eperisone hydrochloride. The accuracy of 
the proposed method was studied by recovery studies at three levels 
(80%, 100% and 120%).  
 
Fig. 2: Typical chromatogram obtained for Standard 
 
The % recovery was found to be in the range of 99.61 to 101.87 for 
Eperisone hydrochloride shows the accuracy of method. The 
precision of the proposed method was studied by interday and 
intraday precision. The method was found to be accurate and 
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precise, as indicated by recovery studies and % RSD not more than 2 
reflects the method is precise. The summary of validation 
parameters of proposed HPTLC method is given in (Table 4).  
 
 
Fig. 3: Typical chromatogram obtained for sample 
 
The degradation studies indicated that Eperisone hydrochloride was 
stable to acid under experimental condition without giving any 
additional degradation peak (Figure 5). The chromatogram of base 
and oxidative degraded sample of Eperisone hydrochloride showed 
one degradation peak in each condition (Figure 6, 7). 
 
 
Fig. 4: Calibration curve for Eperisone hydrochloride 
 
Table 1: Assay of Tablet Dosage Form (Eprisan
S. No. 
®) 




Mean ± SD % RSD* 
 
1 50 101.2 101.04±0.088 0.307 
2 50 101.4 
3 50 101.1 
 *n=3, SD=Standard Deviation, % RSD = % Relative Standard Deviation 
 
Table 2: Precision results for Eperisone hydrochloride 
Drug 
 
Concentration of drug (ng/band) 
 
Absorbance  
(Mean ± S. D)* 
% RSD* 
Repeatability 400 5213.1+2.13 0.0409 
Intraday 400 5224+1.9 0.0376 
Interday 400 5225+0.8164 0.0156 
 *n=6 
 
Table 3: Accuracy Results for Eperisone hydrochloride 
Spike level 
 
Amount added(ng/band) Amount recovered 
(ng/band) 
% Recovery Mean% recovery %RSD 
 80% 
 
 720  
 
 723  100.42  100.06  0.430 
 721.1  100.1  
 
 
  717   99.50 
 100%  
 
 800  810  101.2  101.11  0.181 
 807.8  100.9  
 
 
  808.9  101.1 
 120%  880  874  99.32  99.46  0.161 
 874.9  99.42   
 876.8  99.64 
*n=3, SD=Standard Deviation, % RSD = % Relative Standard Deviation 
 
 
Fig. 5: Chromatogram of Acid degradation condition 
Table 4: Summary of Validation Parameters 
Parameter Eperisone  
hydrochloride 
Linearity range (ng/ spot) 100-700 
Correlation co-efficient 0.999 
Slope (m) 12.69  
Intercept (c) 131 
Precision (intraday) %RSD 0.0376 
Precision (interday) %RSD 0.0156 
Accuracy (Mean % recovery) 101.11% 
LOD (ng /spot) 100 
LOQ (ng /spot) 300 
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Fig. 6: Chromatogram of alkaline degradation condition 
 
 
Fig. 7: Chromatogram of Oxidative degradation condition 
 
CONCLUSION 
A stability-indicating RP-HPLC method of Eperisone hydrochloride 
was developed and validated as per ICH guidelines. The degradation 
behavior of Eperisone hydrochloride was studied under various 
stress conditions of acid, alkali and oxidation. Drug was found to be 
unstable in basic and oxidative condition. The developed method is 
rapid, economic, accurate and precise for quantitative analysis of 
Eperisone hydrochloride in bulk drug. 
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